P01 A Comprehensive Review and Shiny Application on the Matching-Adjusted Indirect Comparison (MAIC)

Conference: ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop 2024
09/27/2024: 9:45 AM - 10:30 AM EDT
Posters 
Room: White Oak 

Description

Population-adjusted indirect comparison (PAIC) is an increasingly used technique for estimating the comparative effectiveness of different treatments for the health technology assessments when head-to-head trials are unavailable. Three commonly used PAIC methods include matching-adjusted indirect comparison (MAIC), simulated treatment comparison (STC), and multilevel network meta-regression (ML-NMR). MAIC enables researchers to achieve balanced covariate distribution across two independent trials when individual participant data (IPD) is only available in one trial. In this paper, we provide a comprehensive review of the MAIC methods, including their theoretical derivation, implicit assumptions, and connection to calibration estimation (CE) in survey sampling. We discuss the nuances between anchored and unanchored MAIC, as well as their required assumptions. Furthermore, we implement various MAIC methods in a user-friendly R Shiny application Shiny-MAIC. To our knowledge, it is the first Shiny application that implements various MAIC methods. The Shiny-MAIC application offers choice between anchored or unanchored MAIC, choice among different types of covariates and outcomes, and two variance estimators including bootstrap and robust standard errors. An example with simulated data is provided to demonstrate the utility of the Shiny-MAIC application, enabling a user-friendly approach conducting MAIC for healthcare decision-making. The Shiny-MAIC is freely available through the link: https://ziren.shinyapps.io/Shiny_MAIC/.

Presenting Author

Ziren Jiang, University Of Minnesota

CoAuthor(s)

Joseph Cappelleri, Pfizer Inc
Margaret Gamalo-Siebers, Pfizer
Yong Chen, University of Pennsylvania, Perelman School of Medicine
Neal Thomas, Pfizer
Haitao Chu, Pfizer

Topic Description

Decision Analysis (e.g., Go/No-Go, Benefit:Risk Determination, Patient-Preference)
ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop 2024